Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular smooth muscle (VSM) contractile machinery and ion channels constitute the primary physiological system for regulating vascular resistance and blood pressure. Contraction is driven by the interaction of actin and myosin, which is triggered by the phosphorylation of the 20-kDa myosin light chain (MLC20) by myosin light chain kinase (MLCK) (StatPearls, 2023). This process is highly dependent on intracellular calcium levels, which are primarily regulated by L-type voltage-gated calcium channels (VGCCs) and sarcoplasmic reticulum release (PubMed, PMID: 10951113). Relaxation occurs when myosin light chain phosphatase (MLCP) dephosphorylates MLC20, a process promoted by the nitric oxide/cGMP/PKG pathway and inhibited by the Rho-kinase (ROCK) pathway (NIH, 2022). Ion channels such as large-conductance calcium-activated potassium (BKCa) channels and ATP-sensitive potassium (KATP) channels modulate membrane potential to provide feedback regulation and induce vasodilation. Pharmacological targeting of these components is a cornerstone in treating hypertension and vasospastic disorders. For example, calcium channel blockers like amlodipine inhibit calcium influx, while ROCK inhibitors like fasudil prevent the inhibition of MLCP (PubChem, 2024). This target group is essential for maintaining hemodynamic stability but is often dysregulated in chronic cardiovascular diseases.
Inhibition of L-type voltage-gated calcium channels to reduce calcium influx; activation of soluble guanylate cyclase to increase cGMP and activate myosin light chain phosphatase; inhibition of Rho-associated protein kinase (ROCK) to prevent phosphatase inhibition; and opening of potassium channels to induce membrane hyperpolarization.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle contractile machinery and ion channels.